INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 May 2016
Net Assets |
£199m |
Net Assets per share |
519p |
Share price |
450p |
Total value of unquoted investments |
£21m |
Total number of portfolio companies |
82 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
7.6 |
Biogen |
6.9 |
Regeneron |
6.2 |
Genmab |
5.6 |
Alexion |
4.6 |
Amgen |
4.3 |
Ophthotech |
3.6 |
Vertex |
3.5 |
Biomarin |
3.4 |
Gilead |
3.1 |
|
----------- |
Total |
48.8 |
Portfolio Revenue Split |
% NAV |
Revenue Generating |
75 |
Near Revenue |
3 |
No sales in the near term |
22 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
78 |
Europe & UK |
22 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
90 |
Unquoted |
10 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
10 JUNE 2016